Merck & Co Inc
(LTS:0QAH)
$
131.3
0 (0%)
Market Cap: 249.37 Bil
Enterprise Value: 272.91 Bil
PE Ratio: 20.67
PB Ratio: 5.61
GF Score: 81/100 
Merck & Co Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 12, 2020 / 07:40PM GMT
Release Date Price:
$75.71
(+1.16%)
Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst
Okay. Good afternoon, everyone, and welcome to the first day of the afternoon session for the BofA Virtual Vegas Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA, and Olivia Brayer from my team is also on the line.
And we're thrilled to have Merck present this afternoon, and we have with us Frank Clyburn, who's Executive Vice President and Chief Commercial Officer, Frank you there?
Franklin K. Clyburn
Merck & Co., Inc. - Chief Commercial Officer & Executive VP
I am, Geoff. Can you hear me?
Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst
Yes. Perfect.
Franklin K. Clyburn
Merck & Co., Inc. - Chief Commercial Officer & Executive VP
Okay. Good.
Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst
And we also
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers